New Delhi, June 20, 2018: Drug major Cipla on Tuesday said it has received approval from the US health regulator to market Efavirenz…
Move will boost the CORONA growth story, marking its entry into thyroid management and fortifying its anti-diabetic portfolio. Ahmedabad, April 03,…